Curis
CRIS
$14.47
Share price
-0.34%
Change (1 day)
1,731.65%
Change (1 year)
Categories
Curis (CRIS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $57.61 M
According to Curis's latest financial reports the company's total liabilities are $57.61 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Curis - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $57.61 M | -7.52% |
| 2022-12-31 | $62.29 M | -12.99% |
| 2021-12-31 | $71.59 M | -2.84% |
| 2020-12-31 | $73.68 M | 6.77% |
| 2019-12-31 | $69.01 M | 64.87% |
| 2018-12-31 | $41.86 M | -15.95% |
| 2017-12-31 | $49.8 M | 74.84% |
| 2016-12-31 | $28.48 M | -6.47% |
| 2015-12-31 | $30.45 M | -7.23% |
| 2014-12-31 | $32.82 M | -7.31% |
| 2013-12-31 | $35.41 M | -0.24% |
| 2012-12-31 | $35.5 M | 327.51% |
| 2011-12-31 | $8.3 M | 61.83% |
| 2010-12-31 | $5.13 M | 68.41% |
| 2009-12-31 | $3.04 M | 10.51% |
| 2008-12-31 | $2.75 M | -60.45% |
| 2007-12-31 | $6.97 M | -57.41% |
| 2006-12-31 | $16.37 M | -28.56% |
| 2005-12-31 | $22.91 M | 20.48% |
| 2004-12-31 | $19.02 M | 12.74% |
| 2003-12-31 | $16.87 M | -61.57% |
| 2002-12-31 | $43.89 M | 0.37% |
| 2001-12-31 | $43.73 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 238,067.40% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | 113,893.61% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $80.87 M | 40.37% | 🇺🇸 USA |
 Exelixis EXEL | $0.67 B | 1,077.61% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $36.45 M | -36.72% | 🇺🇸 USA |
 Cel-Sci
CVM | $16.06 M | -72.12% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.17 B | 1,937.60% | 🇺🇸 USA |